NasdaqGM - Delayed Quote USD
Exagen Inc. (XGN)
5.71
-0.45
(-7.31%)
At close: May 9 at 4:00:00 PM EDT
5.72
+0.01
+(0.18%)
Pre-Market: 8:00:08 AM EDT
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 3 | 3 | 3 | 3 |
| Avg. Estimate | -0.14 | -0.14 | -0.56 | -0.25 |
| Low Estimate | -0.18 | -0.15 | -0.61 | -0.3 |
| High Estimate | -0.12 | -0.13 | -0.53 | -0.21 |
| Year Ago EPS | -0.16 | -0.28 | -0.83 | -0.56 |
Revenue Estimate
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| No. of Analysts | 4 | 4 | 4 | 5 |
| Avg. Estimate | 16.23M | 16.53M | 65.86M | 74.6M |
| Low Estimate | 15.4M | 15.82M | 65.13M | 73.97M |
| High Estimate | 16.64M | 17M | 67M | 75.2M |
| Year Ago Sales | 15.06M | 12.51M | 55.64M | 65.86M |
| Sales Growth (year/est) | 7.77% | 32.17% | 18.36% | 13.28% |
Earnings History
| Currency in USD | 6/30/2024 | 9/30/2024 | 12/31/2024 | 3/31/2025 |
|---|---|---|---|---|
| EPS Est. | -0.35 | -0.28 | -0.24 | -0.21 |
| EPS Actual | -0.16 | -0.28 | -0.2 | -0.2 |
| Difference | 0.19 | 0 | 0.04 | 0.01 |
| Surprise % | 53.96% | 1.75% | 16.67% | 3.23% |
EPS Trend
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Current Estimate | -0.14 | -0.14 | -0.56 | -0.25 |
| 7 Days Ago | -0.12 | -0.13 | -0.54 | -0.26 |
| 30 Days Ago | -0.12 | -0.13 | -0.54 | -0.26 |
| 60 Days Ago | -0.17 | -0.17 | -0.73 | -0.45 |
| 90 Days Ago | -0.17 | -0.17 | -0.73 | -0.45 |
EPS Revisions
| Currency in USD | Current Qtr. (Jun 2025) | Next Qtr. (Sep 2025) | Current Year (2025) | Next Year (2026) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | 3 | -- |
| Down Last 7 Days | 2 | 1 | 1 | 1 |
| Down Last 30 Days | 2 | 1 | -- | 1 |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| XGN | 12.50% | 50.00% | 32.53% | 54.76% |
| S&P 500 | 13.21% | 3.06% | 8.01% | 13.77% |
Upgrades & Downgrades
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 1/13/2025 |
| Maintains | Canaccord Genuity: Buy to Buy | 1/3/2025 |
| Maintains | Cantor Fitzgerald: Overweight to Overweight | 5/14/2024 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 9/26/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 8/22/2023 |
| Reiterates | Cantor Fitzgerald: Overweight to Overweight | 5/16/2023 |
Related Tickers
NOTV Inotiv, Inc.
1.9600
-11.51%
VCYT Veracyte, Inc.
29.71
-4.81%
BDSX Biodesix, Inc.
0.3716
+6.84%
CSTL Castle Biosciences, Inc.
16.79
-2.47%
VIMIAN.ST Vimian Group AB (publ)
39.04
-0.91%
CRL Charles River Laboratories International, Inc.
138.79
-1.82%
RDNT RadNet, Inc.
55.74
-1.14%
MYGN Myriad Genetics, Inc.
3.8900
-3.47%
CHEK Check-Cap Ltd.
0.8193
-7.93%
PSNL Personalis, Inc.
5.04
-2.33%